These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
236 related articles for article (PubMed ID: 30914031)
1. Atrial and Brain Natriuretic Peptides- Benefits and Limits of their use in Cardiovascular Diseases. Roxana ME; Georgică T; Ionuț D; Gianina M; Cristina F Curr Cardiol Rev; 2019; 15(4):283-290. PubMed ID: 30914031 [TBL] [Abstract][Full Text] [Related]
2. Natriuretic peptides: an update on bioactivity, potential therapeutic use, and implication in cardiovascular diseases. Rubattu S; Sciarretta S; Valenti V; Stanzione R; Volpe M Am J Hypertens; 2008 Jul; 21(7):733-41. PubMed ID: 18464748 [TBL] [Abstract][Full Text] [Related]
3. Natriuretic peptides in cardiovascular diseases. Piechota M; Banach M; Jacoń A; Rysz J Cell Mol Biol Lett; 2008; 13(2):155-81. PubMed ID: 17965966 [TBL] [Abstract][Full Text] [Related]
4. The renal and cardiovascular effects of natriuretic peptides. Wong PC; Guo J; Zhang A Adv Physiol Educ; 2017 Jun; 41(2):179-185. PubMed ID: 28377431 [TBL] [Abstract][Full Text] [Related]
6. Will sacubitril-valsartan diminish the clinical utility of B-type natriuretic peptide testing in acute cardiac care? Mair J; Lindahl B; Giannitsis E; Huber K; Thygesen K; Plebani M; Möckel M; Müller C; Jaffe AS; Eur Heart J Acute Cardiovasc Care; 2017 Jun; 6(4):321-328. PubMed ID: 26758541 [TBL] [Abstract][Full Text] [Related]
7. Effects of sacubitril/valsartan on neprilysin targets and the metabolism of natriuretic peptides in chronic heart failure: a mechanistic clinical study. Nougué H; Pezel T; Picard F; Sadoune M; Arrigo M; Beauvais F; Launay JM; Cohen-Solal A; Vodovar N; Logeart D Eur J Heart Fail; 2019 May; 21(5):598-605. PubMed ID: 30520545 [TBL] [Abstract][Full Text] [Related]
8. [Physiology and clinical role of natriuretic peptides]. Szabó G; Rigó J; Nagy B Orv Hetil; 2011 Jun; 152(26):1025-34. PubMed ID: 21652296 [TBL] [Abstract][Full Text] [Related]
9. Cardiovascular Pleiotropic Effects of Natriuretic Peptides. Forte M; Madonna M; Schiavon S; Valenti V; Versaci F; Zoccai GB; Frati G; Sciarretta S Int J Mol Sci; 2019 Aug; 20(16):. PubMed ID: 31398927 [TBL] [Abstract][Full Text] [Related]
11. Natriuretic Peptides: It Is Time for Guided Therapeutic Strategies Based on Their Molecular Mechanisms. Gallo G; Rubattu S; Autore C; Volpe M Int J Mol Sci; 2023 Mar; 24(6):. PubMed ID: 36982204 [TBL] [Abstract][Full Text] [Related]
12. Cardiovascular and metabolic effects of natriuretic peptides. Moro C; Berlan M Fundam Clin Pharmacol; 2006 Feb; 20(1):41-9. PubMed ID: 16448393 [TBL] [Abstract][Full Text] [Related]
17. Evolving Role of Natriuretic Peptides from Diagnostic Tool to Therapeutic Modality. Pagel-Langenickel I Adv Exp Med Biol; 2018; 1067():109-131. PubMed ID: 29411335 [TBL] [Abstract][Full Text] [Related]
18. Plasma natriuretic peptide levels and the risk of cardiovascular events and death. Wang TJ; Larson MG; Levy D; Benjamin EJ; Leip EP; Omland T; Wolf PA; Vasan RS N Engl J Med; 2004 Feb; 350(7):655-63. PubMed ID: 14960742 [TBL] [Abstract][Full Text] [Related]
19. [Recent advances in natriuretic peptide family genes and cardiovascular diseases]. Wu ZJ; Jin W; Zhang FR; Liu Y Yi Chuan; 2012 Feb; 34(2):127-33. PubMed ID: 22382054 [TBL] [Abstract][Full Text] [Related]
20. [Natriuretic peptides: their role in diagnosis and therapy]. Pakuła D; Marek B; Kajdaniuk D; Kos-Kudła B; Borgiel-Marek H; Krysiak R; Gatnar A; Pakuła P Endokrynol Pol; 2007; 58(4):364-74. PubMed ID: 18058731 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]